ZA982818B - Prevention of breast cancer using selective estrogen receptor modulators. - Google Patents

Prevention of breast cancer using selective estrogen receptor modulators.

Info

Publication number
ZA982818B
ZA982818B ZA9802818A ZA982818A ZA982818B ZA 982818 B ZA982818 B ZA 982818B ZA 9802818 A ZA9802818 A ZA 9802818A ZA 982818 A ZA982818 A ZA 982818A ZA 982818 B ZA982818 B ZA 982818B
Authority
ZA
South Africa
Prior art keywords
prevention
breast cancer
estrogen receptor
receptor modulators
selective estrogen
Prior art date
Application number
ZA9802818A
Inventor
Andrew Lawrence Glasebrook
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA982818B publication Critical patent/ZA982818B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
ZA9802818A 1997-04-09 1998-04-02 Prevention of breast cancer using selective estrogen receptor modulators. ZA982818B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4311897P 1997-04-09 1997-04-09

Publications (1)

Publication Number Publication Date
ZA982818B true ZA982818B (en) 1999-10-04

Family

ID=21925594

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9802818A ZA982818B (en) 1997-04-09 1998-04-02 Prevention of breast cancer using selective estrogen receptor modulators.

Country Status (15)

Country Link
EP (1) EP0975628A4 (en)
JP (1) JP2001518897A (en)
KR (1) KR20010006215A (en)
CN (1) CN1259945A (en)
AU (1) AU6957398A (en)
CA (1) CA2286207A1 (en)
EA (1) EA199900910A1 (en)
HU (1) HUP0001845A2 (en)
ID (1) ID23653A (en)
IL (1) IL132279A0 (en)
NO (1) NO994902L (en)
PL (1) PL336206A1 (en)
TR (1) TR199903244T2 (en)
WO (1) WO1998045286A1 (en)
ZA (1) ZA982818B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610706B1 (en) 1999-07-29 2003-08-26 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
US6653479B1 (en) 1999-07-29 2003-11-25 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
BRPI0818637A2 (en) 2007-10-16 2015-04-07 Repros Therapeutics Inc Methods of treating symptom of impaired fasting glucose, metabolic syndrome, metabolic syndrome, and impaired fasting glucose in subjects with secondary or idiopathic hypogonadotropic hypogonadism
EP2819676B1 (en) 2012-02-29 2018-05-30 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
DK2958907T3 (en) 2013-02-19 2018-06-06 Novartis Ag Thus, benzothiophene derivatives and compositions as selective estrogen receptor degraders
GB201311888D0 (en) * 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
SI0729956T1 (en) * 1995-02-28 2002-04-30 Eli Lilly And Company Benzothiophene compounds, intermediates, compositions, and methods
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods

Also Published As

Publication number Publication date
JP2001518897A (en) 2001-10-16
EA199900910A1 (en) 2000-04-24
NO994902D0 (en) 1999-10-08
ID23653A (en) 2000-05-11
TR199903244T2 (en) 2000-05-22
PL336206A1 (en) 2000-06-05
EP0975628A4 (en) 2001-03-21
IL132279A0 (en) 2001-03-19
CN1259945A (en) 2000-07-12
NO994902L (en) 1999-12-07
WO1998045286A1 (en) 1998-10-15
CA2286207A1 (en) 1998-10-15
KR20010006215A (en) 2001-01-26
AU6957398A (en) 1998-10-30
EP0975628A1 (en) 2000-02-02
HUP0001845A2 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
ZA200108846B (en) Glucocorticoid receptor modulators.
HK1035671A1 (en) Adenosine a3 receptor modulators.
AU4557099A (en) Novel therapeutic agents that modulate estrogen receptors
ZA991301B (en) Glutamate receptor modulators.
AU1199600A (en) Estrogen receptor ligands
ZA966721B (en) Bowl for hand mixing.
HUP9700636A3 (en) Novel estrogen receptor
ZA982818B (en) Prevention of breast cancer using selective estrogen receptor modulators.
EP1084142A4 (en) Gpr35a receptor
EP0973800A4 (en) Novel receptor
ZA981338B (en) Neurturin receptor.
GB9928566D0 (en) Human vanilloid receptor-like receptor
GB9803062D0 (en) Estrogen receptor ligands
GB9913649D0 (en) Estrogen receptor
EP1083909A4 (en) hCEPR RECEPTOR
GB9722884D0 (en) Estrogen receptor
GB9711992D0 (en) Estrogen receptor ligands
GB9717346D0 (en) Estrogen receptor ligands
GB9806032D0 (en) Estrogen receptor
EP1109565A4 (en) Gabab1aa receptor
GB9803202D0 (en) Estrogen Receptor Ligands
GB9803061D0 (en) Estrogen receptor ligands
GB9808613D0 (en) Receptor system
ZA987210B (en) Droloxifene for prevention of breast cancer.
PL338610A1 (en) Novel non-steroidic ligands of an oestrogen receptor